{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:39:33Z","timestamp":1789205973736,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39357-y","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:46:46Z","timestamp":1772531206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A high density of T-cell lymphocytes and Tregs subset correlate to a worse survival in major salivary gland carcinomas"],"prefix":"10.1038","volume":"16","author":[{"given":"Debora","family":"Anconelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vasuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Saragoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Messerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Saieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Muscatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Amedei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Raffaella","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"39357_CR1","unstructured":"Lyon (France). International Agency for Research on Cancer, WHO Classification of Tumours Editorial Board. Head and neck tumours. 2022., 5th ed., vol. 9. (2022)."},{"key":"39357_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/hed.27307","volume":"45","author":"AN Weaver","year":"2023","unstructured":"Weaver, A. N., Lakritz, S., Mandair, D., Ulanja, M. B. & Bowles, D. W. A molecular guide to systemic therapy in salivary gland carcinoma. Head Neck. 45, 1315\u20131326. https:\/\/doi.org\/10.1002\/hed.27307 (2023).","journal-title":"Head Neck"},{"key":"39357_CR3","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1158\/1078-0432.CCR-19-3758","volume":"26","author":"M Linxweiler","year":"2020","unstructured":"Linxweiler, M. et al. The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype. Clin. Cancer Res. 26, 2859\u20132870. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-3758 (2020).","journal-title":"Clin. Cancer Res."},{"key":"39357_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1245\/s10434-008-0259-6","volume":"16","author":"YS Shieh","year":"2009","unstructured":"Shieh, Y. S. et al. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of the salivary glands. Ann. Surg. Oncol. 16, 751\u2013760. https:\/\/doi.org\/10.1245\/s10434-008-0259-6 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"39357_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12307-010-0051-6","volume":"4","author":"M Dutsh-Wicherek","year":"2010","unstructured":"Dutsh-Wicherek, M., Lazar, A. & Tomaszewska, R. The involvement of RCAS1 in creating a suppressive tumor microenviroment in patients with salivary gland adenocarcinoma. Cancer Microenviron. 4, 13\u201321. https:\/\/doi.org\/10.1007\/s12307-010-0051-6 (2010).","journal-title":"Cancer Microenviron"},{"key":"39357_CR6","doi-asserted-by":"publisher","first-page":"1163565","DOI":"10.3389\/fmed.2023.1163565","volume":"10","author":"A De Virgilio","year":"2023","unstructured":"De Virgilio, A. et al. Tumor-infiltrating lymphocytes and tumor-associated macrophages as potential predictors of lymph node metastases in major salivary gland cancer. Front. Med. 10, 1163565. https:\/\/doi.org\/10.3389\/fmed.2023.1163565 (2023).","journal-title":"Front. Med."},{"key":"39357_CR7","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1038\/s41467-025-60421-0","volume":"16","author":"E Zuljan","year":"2025","unstructured":"Zuljan, E. et al. A macrophage-predominant immunosuppressive microenvironment and therapeutic vulnerabilities in advanced salivary gland cancer. Nat. Commun. 16, 5303. https:\/\/doi.org\/10.1038\/s41467-025-60421-0 (2025).","journal-title":"Nat. Commun."},{"key":"39357_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/modpathol.2008.191","volume":"22","author":"B Clarke","year":"2009","unstructured":"Clarke, B. et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod. Pathol. 22, 393\u2013402. https:\/\/doi.org\/10.1038\/modpathol.2008.191 (2009).","journal-title":"Mod. Pathol."},{"key":"39357_CR9","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/j.gastro.2009.06.053","volume":"137","author":"FA Sinicrope","year":"2009","unstructured":"Sinicrope, F. A. et al. Intraepithelial effector (CD3+)\/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 137, 1270\u20131279. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.053 (2009).","journal-title":"Gastroenterology"},{"key":"39357_CR10","first-page":"5555","volume":"34","author":"P Cermakova","year":"2014","unstructured":"Cermakova, P. et al. Prognostic significance of CD3\u2009+\u2009tumor-infiltrating lymphocytes in patients with endometrial carcinoma. Anticancer Res. 34, 5555\u20135561 (2014).","journal-title":"Anticancer Res."},{"key":"39357_CR11","doi-asserted-by":"publisher","first-page":"573158","DOI":"10.3389\/fimmu.2020.573158","volume":"11","author":"E Niccolai","year":"2021","unstructured":"Niccolai, E. et al. Significant and conflicting correlation of IL-9 with prevotella and bacteroides in human colorectal cancer. Front. Immunol. 11, 573158. https:\/\/doi.org\/10.3389\/fimmu.2020.573158 (2021).","journal-title":"Front. Immunol."},{"key":"39357_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/CS20150437","volume":"130","author":"E Niccolai","year":"2016","unstructured":"Niccolai, E. et al. Intra-tumoral IFN-\u03b3-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer. Clin. Sci. 130, 247\u2013258. https:\/\/doi.org\/10.1042\/CS20150437 (2016).","journal-title":"Clin. Sci."},{"key":"39357_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12885-018-4069-3","volume":"18","author":"K Harada","year":"2018","unstructured":"Harada, K., Ferdous, T. & Ueyama, Y. PD-L1 expression in malignant salivary gland tumors. BMC Cancer. 18, 156. https:\/\/doi.org\/10.1186\/s12885-018-4069-3 (2018).","journal-title":"BMC Cancer"},{"key":"39357_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12105-025-01798-8","volume":"19","author":"Y Noda","year":"2025","unstructured":"Noda, Y. et al. PD-L1 staining using clone 73\u2009\u2013\u200910 antibody and Spatial transcriptomics for precise expression analysis in Non-Tumorous, intraepithelial Neoplasia, and squamous cell carcinoma of head and neck. Head Neck Pathol. 19, 65 (2025).","journal-title":"Head Neck Pathol."},{"key":"39357_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12105-025-01815-w","volume":"19","author":"Y Noda","year":"2025","unstructured":"Noda, Y., Yagi, M. & Tsuta, K. Spatial transcriptome analysis of B7-H4 in head and neck squamous cell carcinoma: A novel therapeutic target for Anti-Immune checkpoint inhibitors. Head Neck Pathol. 19, 78. https:\/\/doi.org\/10.1007\/s12105-025-01815-w (2025).","journal-title":"Head Neck Pathol."},{"key":"39357_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oraloncology.2018.11.028","volume":"88","author":"C Mosconi","year":"2019","unstructured":"Mosconi, C. et al. Immune microenviroment and evasion mechanism in adenoid cystic carcinomas of the salivary glands. Oral Oncol. 88, 95\u2013101. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.11.028 (2019).","journal-title":"Oral Oncol."},{"key":"39357_CR17","doi-asserted-by":"publisher","first-page":"104931","DOI":"10.1016\/j.oraloncology.2020.104931","volume":"111","author":"N Kesar","year":"2020","unstructured":"Kesar, N. et al. Prognostic impact of CD8-positive tumour-inphiltrating lymphocytes and PD-L1 expression in salivary gland cancer. Oral Oncol. 111, 104931. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104931 (2020).","journal-title":"Oral Oncol."},{"key":"39357_CR18","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.7150\/thno.42986","volume":"10","author":"M Alame","year":"2020","unstructured":"Alame, M. et al. The molecular landscape Ond microenviroment of salivary duct carcinoma reveal new therapeutic opportunities. Theranostics 10, 4383\u20134394. https:\/\/doi.org\/10.7150\/thno.42986 (2020).","journal-title":"Theranostics"},{"key":"39357_CR19","doi-asserted-by":"publisher","first-page":"E1481","DOI":"10.1002\/lary.29120","volume":"131","author":"F Sato","year":"2021","unstructured":"Sato, F. et al. Prognostic value of tumor proportion score in salivary gland carcinoma. Laryngoscope 131, E1481\u2013E1488. https:\/\/doi.org\/10.1002\/lary.29120 (2021).","journal-title":"Laryngoscope"},{"key":"39357_CR20","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.25011\/cim.v44i1.35218","volume":"44","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. Assessment of tumor infiltrating lymphocytes and PD-L1 expression in adenoid cystic carcinoma of the salivary gland. Clin. Invest. Med. 44, E38\u201341. https:\/\/doi.org\/10.25011\/cim.v44i1.35218 (2021).","journal-title":"Clin. Invest. Med."},{"key":"39357_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s12105-020-01163-x","volume":"14","author":"K Chatzopoulos","year":"2020","unstructured":"Chatzopoulos, K. et al. Increased ERBB2 gene copy number reveal a subset of salivary duct carcinoma with high densities of tumour inphiltrating lymphocytes an PD-L1 expression. Head Neck Pathol. 14, 951\u2013965. https:\/\/doi.org\/10.1007\/s12105-020-01163-x (2020).","journal-title":"Head Neck Pathol."},{"key":"39357_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/2326-6066.CIR-16-0031","volume":"4","author":"V Sridharan","year":"2016","unstructured":"Sridharan, V. et al. Immune profiling of adenoid cystic carcinoma: PD-L2 expression and associations with Tumor-Infiltrating lymphocytes. Cancer Immunol. Res. 4, 679\u2013687. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0031 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"39357_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jop.12429","volume":"45","author":"J Lemound","year":"2016","unstructured":"Lemound, J. et al. Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas. J. Oral Pathol. Med. 45, 655\u2013663. https:\/\/doi.org\/10.1111\/jop.12429 (2016).","journal-title":"J. Oral Pathol. Med."},{"key":"39357_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.imlet.2015.02.008","volume":"164","author":"MR Haghshenas","year":"2015","unstructured":"Haghshenas, M. R., Khademi, B., Faghih, Z., Ghaderi, A. & Erfani, N. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunol. Lett. 164, 109\u2013116. https:\/\/doi.org\/10.1016\/j.imlet.2015.02.008 (2015).","journal-title":"Immunol. Lett."},{"key":"39357_CR25","doi-asserted-by":"publisher","unstructured":"Tao, R. et al. Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment. NPJ Prec Oncol. 8 (15). https:\/\/doi.org\/10.1038\/s41698-024-00501-4 (2024).","DOI":"10.1038\/s41698-024-00501-4"},{"key":"39357_CR26","doi-asserted-by":"publisher","first-page":"15821","DOI":"10.1038\/s41598-024-66709-3","volume":"14","author":"J Tasoulas","year":"2024","unstructured":"Tasoulas, J. et al. Molecular characterization of the salivary adenoid cystic carcinoma immune landscape by anatomic subsites. Sci. Rep. 14, 15821. https:\/\/doi.org\/10.1038\/s41598-024-66709-3 (2024).","journal-title":"Sci. Rep."},{"key":"39357_CR27","doi-asserted-by":"publisher","unstructured":"Humphries, M. P. et al. Automated tumour recognition and digital pathology scoring unravels new role of PD-L1 in predicting good outcome in ER-\/HER2\u2009+\u2009breast cancer. J. Oncol. 293701 https:\/\/doi.org\/10.1155\/2018\/2937012 (2018).","DOI":"10.1155\/2018\/2937012"},{"key":"39357_CR28","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","volume":"5","author":"S Lu","year":"2019","unstructured":"Lu, S. et al. Comparison of biomarker modalities for predicting response to PD1\/PD-L1 checkpoint Blockade. JAMA Oncol. 5, 1195\u20131204. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1549 (2019).","journal-title":"JAMA Oncol."},{"key":"39357_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cac2.12023","volume":"40","author":"WCC Tan","year":"2020","unstructured":"Tan, W. C. C. et al. Overview of multiplex immunohistochemistry\/immunofluorescence tecniques in the era of cancer immunotherapy. Cancer Commun. Lond. 40, 135\u2013153. https:\/\/doi.org\/10.1002\/cac2.12023 (2020).","journal-title":"Cancer Commun. Lond."},{"key":"39357_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00000478-200107000-00001","volume":"25","author":"MS Brandwein","year":"2001","unstructured":"Brandwein, M. S. et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am. J. Surg. Pathol. 25, 835\u2013845. https:\/\/doi.org\/10.1097\/00000478-200107000-00001 (2001).","journal-title":"Am. J. Surg. Pathol."},{"key":"39357_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hed.24613","volume":"39","author":"S van Weert","year":"2017","unstructured":"van Weert, S. et al. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck. Head Neck. 39, 456\u2013463. https:\/\/doi.org\/10.1002\/hed.24613 (2017).","journal-title":"Head Neck"},{"key":"39357_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.oooo.2012.11.018","volume":"115","author":"CY Zhang","year":"2013","unstructured":"Zhang, C. Y. et al. Adenoid cystic carcinoma of the head and neck: clinicopathologic analysis of 218 cases in a Chinese population. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 115, 368\u2013375. https:\/\/doi.org\/10.1016\/j.oooo.2012.11.018 (2013).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"39357_CR33","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/PAS.0000000000000918","volume":"41","author":"B Xu","year":"2017","unstructured":"Xu, B. et al. Predictors of outcome in adenoid cystic carcinoma of salivary glands: A clinicopathologic study with correlation between MYB fusion and protein expression. Am. J. Surg. Pathol. 41, 1422\u20131432. https:\/\/doi.org\/10.1097\/PAS.0000000000000918 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"39357_CR34","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15384047.2016.1235666","volume":"17","author":"V Nardone","year":"2016","unstructured":"Nardone, V. et al. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse. Cancer Biol. Ther. 17, 1213\u20131220. https:\/\/doi.org\/10.1080\/15384047.2016.1235666 (2016).","journal-title":"Cancer Biol. Ther."},{"key":"39357_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.clnesp.2020.05.012","volume":"38","author":"A D\u2019Ignazio","year":"2020","unstructured":"D\u2019Ignazio, A. et al. Preoperative oral immunonutrition in Gastrointestinal surgical patients: how the tumour microenvironment can be modified. Clin. Nutr. ESPEN. 38, 153\u2013159. https:\/\/doi.org\/10.1016\/j.clnesp.2020.05.012 (2020).","journal-title":"Clin. Nutr. ESPEN"},{"key":"39357_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cancers15020437","volume":"15","author":"MR Ambrosio","year":"2023","unstructured":"Ambrosio, M. R. et al. Paving the path for immune enhancing nutrition in colon cancer: modulation of tumor microenvironment and optimization of outcomes and costs. Cancers 15, 437. https:\/\/doi.org\/10.3390\/cancers15020437 (2023).","journal-title":"Cancers"},{"key":"39357_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12105-022-01486-x","volume":"17","author":"S Gerdabi","year":"2023","unstructured":"Gerdabi, S. et al. Simultaneous expression of PD-1 and PD\u2010L1 in peripheral and central immune cells and tumor cells in the benign and malignant salivary gland tumors microenvironment. Head Neck Pathol. 17, 178\u2013192. https:\/\/doi.org\/10.1007\/s12105-022-01486-x (2023).","journal-title":"Head Neck Pathol."},{"key":"39357_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang, K. K. et al. Human papillomavirus and survival of patients with oropharingeal cancer. N.  Engl. J. Med. 363, 24\u201335. https:\/\/doi.org\/10.1056\/NEJMoa0912217 (2010).","journal-title":"N Engl. J. Med."},{"key":"39357_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00129039-200303000-00014","volume":"11","author":"AC Ruifrok","year":"2003","unstructured":"Ruifrok, A. C., Katz, R. L. & Johnston, D. A. Comparison of quantification of histochemical staining by hue-saturation-intensity (HSI) transformation and color-deconvolution. Appl. Immunohistochem. Mol. Morphol. 11, 85\u201391 (2003).","journal-title":"Appl. Immunohistochem. Mol. Morphol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39357-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39357-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:05:57Z","timestamp":1775729157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39357-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39357"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39357-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted according to the guidelines of the Declaration of Helsinki and the STROBE guidelines, and approved by the Ethics Committee of Azienda Sanitaria Toscana Nord-Ovest (code 19542). Informed Consent was obtained at the moment of surgery.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"11794"}}